Related Articles

• Individualized chemotherapy guided by the expression of <em>ERCC1, RRM1, TUBB3, TYMS</em> and <em>TOP2A</em> genes versus classic chemotherapy in the treatment of breast cancer: A comparative effectiveness study
• Prognostic significance of the mRNA expression of ERCC1, RRM1, TUBB3 and TYMS genes in patients with non-small cell lung cancer
• Predictive value of ERCC1 and RRM1 gene single-nucleotide polymorphisms for first-line platinum- and gemcitabine-based chemotherapy in non-small cell lung cancer patients
• EGFR and K-RAS mutations and ERCC1, TUBB3, TYMS, RRM1 and EGFR mRNA expression in non‑small cell lung cancer: Correlation with clinical response to gefitinib or chemotherapy
• Expression of ribonucleoside reductase subunit M1, but not excision repair cross‑complementation group 1, is predictive in muscle‑invasive bladder cancer treated with chemotherapy and radiation